Actively Recruiting

Phase 4
Age: 50Years +
All Genders
NCT07031128

Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)

Led by National University Hospital, Singapore · Updated on 2025-06-22

250

Participants Needed

2

Research Sites

129 weeks

Total Duration

On this page

Sponsors

N

National University Hospital, Singapore

Lead Sponsor

W

Wellcome Leap Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

One of the most common major surgeries that older patients undergo is coronary artery bypass grafting surgery (CABG), which is performed in approximately 400,000 patients in the United States each year. CABG invokes a massive surgical stress response, with systemic epinephrine increasing 33-fold and norepinephrine increasing 3-fold. Initially, local tissue injury results in a sterile inflammation, releasing damage-associated molecular patterns (DAMPS). DAMPS activate neutrophils, bringing a cascade of cytokines, complement, and coagulation changes. Activation of nociceptors results in a neurometabolic response involving the sympathetic nervous system and hypothalamus-pituitary axis. This brings about systemic effects including changes in basal metabolic rate, hyperglycemia, lipolysis, negative nitrogen balance, and release of cytokines and complement. Although the surgical stress response is essential for wound healing and is usually self-limiting, an exaggerated response may occur resulting in multiple organ dysfunction. The acute phase of the surgical stress response is often followed by secondary insults that may be either sterile or pathogen-induced (such as postoperative infection).In the "two-hit" model of surgical stress response, there is an exaggerated response even to minor insults in vulnerable individuals who were primed by the initial stress response. Changes in the microbiome may also occur, developing a "pathobiome" that may enter the systemic circulation. If left unchecked, this second hit may result in the development of systemic inflammatory response syndrome (SIRS) and multi-organ failure. Chronological ageing changes the innate and adaptive immunity of patients. Biological hallmarks of aging such as genomic instability, mitochondrial damage, glycation of proteins, and cellular senescence all result in increased oxidative stress and systemic inflammation. Aging brings about a pro-inflammatory innate immune responsiveness that often occurs even in the absence of an inflammatory threat. This is termed inflammaging. Paradoxically, inflammaging is associated with an increased risk of infection and poor response to stressful events. At the same time, there is an age-associated loss of T-cell function, particularly in naïve CD8 T-cells. This deficit is termed immunosenescence and is characterised by reduced pathogen recognition, chemotaxis, and phagocytosis.

CONDITIONS

Official Title

Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)

Who Can Participate

Age: 50Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Scheduled for elective coronary artery bypass grafting with cardiopulmonary bypass
  • Aged 50 years or older
  • Able to understand and provide informed consent
Not Eligible

You will not qualify if you...

  • Currently taking alpha-ketoglutarate supplements
  • Untreated or treated substance abuse disorder
  • Untreated or poorly controlled mental health conditions such as post-traumatic stress disorder, bipolar disorder, schizophrenia, or recent hospitalization for mental health in the past 3 years
  • Cognitive impairment
  • HIV/AIDS
  • Undergoing or planning chemotherapy or other cancer treatments
  • Scheduled for immunosuppressant therapy for transplant
  • Active infection needing antibiotic or antiviral treatment
  • Pregnant, planning to conceive, or breastfeeding
  • Taking chronic anti-inflammatory drugs like NSAIDs
  • Allergic to alpha-ketoglutarate, placebo, or any tablet components

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

National University Hospital

Singapore, Singapore, Singapore, 119074

Actively Recruiting

2

Singapore General Hospital

Singapore, Singapore

Actively Recruiting

Loading map...

Research Team

L

Lian Kah Ti

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here